Cinnoline compounds for use in the treatment of schizophrenia

Details for Australian Patent Application No. 2008264985 (hide)

Owner AstraZeneca AB

Inventors Chapdelaine, Marc; Arriza, Jeffrey Louis; Christian, Edward

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008264985

PCT Pub. Number WO2008/155573

Priority 60/944,883 19.06.07 US

Filing date 18 June 2008

Wipo publication date 24 December 2008

International Classifications

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/155573 Priority application(s): WO2008/155573

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008264991-Monitoring an immunoassay

2008264984-Fused quinoline derivatives useful as GABA modulators